Supervisor: Dr Amanda W. Kijas ( and Prof. Alan Rowan

Death due to haemorrhage (bleeding) is a preventable death. Yet 30-40% of people in a civilian setting die as a result of bleeding to death. In a military setting 90% of casualties with potentially survivable injuries die due to haemorrhage. This project will specifically target this clinical need, through the design, construction and testing of this portable efficacious haemostatic agent/dressing to control bleeding. We are employing potent snake venom proteins to bring about rapid and stable blood clot formation in combination with biomaterials to target specific wound types.